Check the current and upcoming studies to get in touch!

 

Explore opportunities to participate in current and upcoming medical studies by consulting our complete list. Get in touch with our team today to join our innovative research and help shape the future of healthcare.

Clinic of
Val-BĂ©lair

Telephone  (418) 847-1112
Fax  (418) 847-9134
See the Clinic page
z
Clinic of
Lebourgneuf

Telephone  (418) 704-1112
Fax  (418) 704-1092
See the Clinic page
z
Clinic of
LĂ©vis

Telephone  (418) 847-1112
Fax  (418) 847-9134
See the Clinic page
z

Our studies

Select the current or upcoming studies according to your center of preference

Alzheimer

Men
Women
50 to 90 years old
Administration route: oral
Compensation for travel expenses

Obesity

Overweight or obese adults with osteoarthritis of the knee

Men
Women
40+ years old
Subcutaneous injection
Compensation for travel expenses

Urinary tract infection

Adults with a history of urinary tract infection

Men
Women
60+ years old
Vaccine/intramuscular
Compensation for travel expenses

Alzheimer

Men
Women
50-87 years old
Administration route: oral
Compensation for travel expenses

Dyslipidemia (cholesterol)

Adults with dyslipidemia and established cardiovascular disease

Men
Women
40+ years old
Subcutaneous injection
Compensation for travel expenses

Teen migraines

Boy
Girl
12-17 years old Weight greater than or equal to 40 kg
Administration route: oral
Compensation for travel expenses

Adult migraines

Adults suffering from acute migraines

Men
Women
18-65 years old
Administration route: oral
Compensation for travel expenses

Adult migraines

Adults with migraines

Men
Women
18-65 years old
Administration route: oral
Compensation for travel expenses

Alzheimer

Men
Women
60-85 years old
Subcutaneous injection
Compensation for travel expenses

Alzheimer

Men
Women
60-85 years old
Route of administration: I V injection
Compensation for travel expenses

Depression

Men
Women
18-74 years old
Administration route: oral
Compensation for travel expenses

Obesity

Obese adults with cardiovascular risk factors

Men
Women
18+ years old
subcutaneous injection
Compensation for travel expenses

COPD

Men
Women
40 to 80 years old inclusive
Administration route: oral
Compensation for travel expenses

Non-diasgnostic or mild Alzheimer's disease

Men
Women
60-85 years old
Administration route: Intravenous
Compensation for travel expenses

Non-diasgnostic or mild Alzheimer's disease

Men
Women
60-85 years old
Administration route: Subcutaneous injection
Compensation for travel expenses

Obesity

Overweight or obese adults with osteoarthritis of the knee.

Men
Women
18 to 80 years old
12 to 17 years old (diagnosed 1 year ago)
Inhalation (pump)
Compensation for travel expenses

Depression

Adults with major depression

Men
Women
18-74 years old
Compensation for travel expenses

Asthma

Adults and adolescents with poorly controlled asthma.

Men
Women
18 to 80 years old
12 to 17 years old (diagnosed 1 year ago)
Inhalation (pump)
Compensation for travel expenses

Asthma

Adults with poorly controlled asthma.

Men
Women
18 to 80 years old
Inhalation (pump)
Compensation for travel expenses

COPD

Participants with moderate-to-severe chronic obstructive pulmonary disease (COPD) and a history of frequent exacerbations.

Men
Women
40 to 85 years old
Subcutaneous injection
Compensation for travel expenses

Psoriasis

Adults with plaque psoriasis to understand the impact on quality of life and productivity at work.

Men
Women
18 and over
Subcutaneous injection
Compensation for completing questionnaires

Dyslipidemia (cholesterol)

Adults with dyslipidemia and established cardiovascular disease.

Men
Women
40 and over
WITH events OR cardiovascular risk factors
Compensation for travel expenses

Migraines

Adults with acute migraines

Men
Women
18 to 65 years old
Compressed
Compensation For travel expenses

Migraines

Adults with migraines.

Men
Women
18 to 65 years old
Compressed
Compensation for travel expenses

Urinary tract infection

Adults with a history of urinary tract infection

Men
Women
60 and over
Vaccine/intramuscular
Compensation for travel expenses

Atopic dermatitis

Adults with moderate to severe atopic dermatitis

Men
Women
18 to 80 years old
Subcutaneous injection
Compensation for travel expenses

Obesity

Obese adults with cardiovascular risk factors.

Men
Women
40 and over
Subcutaneous injection
Compensation for travel expenses

Alzheimer

Adults with early symptomatic Alzheimer's disease.

Men
Women
60 to 85 years
Intravenous
Compensation for travel expenses

Alzheimer

Adults with moderate to severe Alzheimer's disease. Screening offered.

Men
Women
60 to 85 years old
Subcutaneous injection
Compensation for travel expenses

Diabetes

Adults with type 2 diabetes

Men
Women
18 and over
Compressed
Compensation for travel expenses

Dyslipidemia (Cholesterol)

Adults at high risk of cardiovascular disease.

Men
Women
18 to 80 years old
12 to 17 years old (diagnosed 1 year ago)
Inhalation (pump)
Compensation for travel expenses

Obesity

Overweight or obese adults with osteoarthritis of the knee.

Men
Women
18 to 80 years old
12 to 17 years old (diagnosed 1 year ago)
Inhalation (pump)
Compensation for travel expenses

Lupus

Adults with systemic lupus erythematosus (SLE) and systemic lupus erythematosus (SLE) with cutaneous manifestations.

Men
Women
18 to 75 years old
Intravenous
Compensation for travel expenses

There's no study for the LĂ©vis clinic!

Study approach

Personalized support

Our team of healthcare professionals stands out for its humane and respectful approach.

alpha-recherche-clinique_pour-les-commanditaires-detude_notre-materiel-et-nos-equipements-perfusion-intraveineuse 01

The first meeting and consent.

During the first visit you will meet with one of the study’s research coordinators. This meeting always begins with the reading of consent where you will have the opportunity to ask your questions. If you agree to participate in the study, you will be asked to sign the consent.

DSC_3090-min 02

The selection period

Once the consent has been signed, the research coordinator will ask you some questions in order to know your medical history. Each search protocol is unique and has a list of inclusion and exclusion criteria. She will also perform some of the procedures required by the protocol. Here are some examples (vital signs, electrocardiogram and blood tests). This data will help assess whether you are potentially eligible for the study. The interventions performed and the duration of this period is unique to each study.

alpha-recherche-clinique_specialisation-en-recherche-clinique-a-quebec 03

Randomization

If you meet all the criteria for the study, you will be able to be randomized, which means you will be able to start the study medication.

alpha-recherche-clinique_nos-etudes_consulter-nos-etudes-en-cours_participer-a-une-autre-etude 04

Treatment phase

During this phase, you receive study medication. There will also be follow-up clinic visits. Some studies also include telephone visits. The coordinator will assess your health by asking you a few questions and collect some data by performing some of the interventions required by the study protocol.

suivi fin de traitement 05

The end of treatment follow-up.

This phase begins when you complete study treatment. The duration and number of visits vary depending on the protocol, but it usually consists of an additional visit approximately 2 to 4 weeks after stopping treatment. The follow-up allows to conclude the study safely. If additional testing is required, the coordinator will contact the medical investigator for additional testing.

Latest news

Expand your knowledge

 

Explore the crucial discoveries of clinical research through our blog posts, offering a serious look at medical advances, illuminating your understanding and stimulating your commitment to health and wellness.

What is obesity?

What is asthma?

What is diabetes?

What is Alzheimer's disease?